this work references cited by second hopReferences
- 1986Agency Costs of Free Cash Flow, Corporate Finance, and Takeovers17,216 cited
- 1996Agency costs of free cash flow, corporate finance, and takeovers9,308 cited
- 2003The price of innovation: new estimates of drug development costs4,264 cited
- 1997Internal Capital Markets and the Competition for Corporate Resources1,779 cited
- 2000The Cost of Diversity: The Diversification Discount and Inefficient Investment1,684 cited
- 2000The Dark Side of Internal Capital Markets: Divisional Rent‐Seeking and Inefficient Investment1,556 cited
- 1998Are Internal capital Markets Efficient?1,050 cited
- 2002Do Conglomerate Firms Allocate Resources Inefficiently Across Industries? Theory and Evidence759 cited
- 1998The Cost of Diversity: The Diversification Discount and Inefficient Investment409 cited
- 2008The Dark Side of Internal Capital Markets: Divisional Rent-Seeking and Inefficient Investment390 cited
- 1998The Dark Side of Internal Capital Markets II: Evidence from Diversified Conglomerates359 cited
- 2003Do equity financing cycles matter? evidence from biotechnology alliances351 cited
- 2005Productivity in pharmaceutical–biotechnology R&D: the role of experience and alliances290 cited
- 2001The Bright Side of Internal Capital Markets267 cited
Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work